FMP

FMP

Enter

XBIO - Xenetic Bioscie...

photo-url-https://images.financialmodelingprep.com/symbol/XBIO.png

Xenetic Biosciences, Inc.

XBIO

NASDAQ

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

4.17 USD

-0.1806 (-4.33%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. James F. Parslow

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Se...

CIK

0001534525

ISIN

US9840156023

CUSIP

984015503

Address

40 Speen Street

Phone

781 778 7720

Country

US

Employee

4

IPO Date

Jun 30, 2016

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

XBIO Financial Summary

CIK

0001534525

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

984015503

ISIN

US9840156023

Country

US

Price

4.17

Beta

2.26

Volume Avg.

24.59k

Market Cap

6.43M

Shares

-

52-Week

2.78-5.2

DCF

-3.07

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.57

P/B

-

Website

https://www.xeneticbio.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest XBIO News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep